Fig. 3From: DPP-4 inhibition enhanced renal tubular and myocardial GLP-1 receptor expression decreased in CKD with myocardial infarctionDipeptidyl-peptidase 4 (DPP-4) activity in chronic kidney disease (CKD) and CKD with linagliptin-treated rats. Control, sham-operated; CKD 2, 4, 8 weeks, 5/6 nephrectomized rats 2, 4, and 8 weeks post-treatment; Lina, linagliptin. Values are presented as the mean ± standard deviation (SD)Back to article page